|
市場調査レポート
商品コード
1559233
ぶどう膜炎薬の世界市場、2024年～2028年Global Uveitis Drugs Market 2024-2028 |
||||||
|
|
|||||||
カスタマイズ可能
|
|||||||
価格
| ぶどう膜炎薬の世界市場、2024年～2028年 |
|
出版日: 2024年08月19日
発行: TechNavio
ページ情報: 英文 143 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
ぶどう膜炎薬市場2024-2028
ぶどう膜炎薬市場は2023-2028年に1億9,850万米ドル、予測期間中のCAGRは4.5%で成長すると予測されます。当レポートでは、ぶどう膜炎薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、眼疾患およびぶどう膜炎の関連リスク因子の高い有病率、眼疾患の診断における最近の進歩、強力なパイプラインによって牽引されています。
| 市場範囲 | |
|---|---|
| 基準年 | 2024 |
| 終了年 | 2028 |
| 予測期間 | 2024-2028 |
| 成長モメンタム | 加速 |
| 前年比2024年 | 4.23% |
| CAGR | 4.5% |
| 増分額 | 1億9,850万米ドル |
本調査では、遺伝子治療の市場開拓が今後数年間のぶどう膜炎薬市場成長を牽引する主要因の1つであるとしています。また、特別な指定や併用療法の人気の高まりは、市場の大きな需要につながります。
目次
第1章 エグゼクティブサマリー
- 市場概要
第2章 市場情勢
- 市場エコシステム
- 市場の特徴
- バリューチェーン分析
第3章 市場規模の評価
- 市場の定義
- 市場セグメント分析
- 市場規模 2023
- 市場の見通し 2023-2028
第4章 市場規模実績
- ぶどう膜炎薬の世界市場 2018-2022
- 製品別セグメント分析 2018-2022
- 地域別セグメント分析 2018-2022
- 国別セグメント分析 2018-2022
第5章 ファイブフォース分析
- ファイブフォースの要約
- 買い手の交渉力
- 供給企業の交渉力
- 新規参入業者の脅威
- 代替品の脅威
- 競争の脅威
- 市況
第6章 市場セグメンテーション：製品別
- 市場セグメンテーション
- 比較：製品別
- 低分子：市場規模と予測 2023-2028
- 生物学的製剤：市場規模と予測 2023-2028
- 市場機会：製品別
第7章 顧客情勢
- 顧客情勢の概要
第8章 地域別情勢
- 地域別セグメンテーション
- 地域別比較
- 北米：市場規模と予測 2023-2028
- 欧州：市場規模と予測 2023-2028
- アジア：市場規模と予測 2023-2028
- 世界のその他の地域：市場規模と予測 2023-2028
- 米国：市場規模と予測 2023-2028
- ドイツ：市場規模と予測 2023-2028
- 英国：市場規模と予測 2023-2028
- カナダ：市場規模と予測 2023-2028
- 中国：市場規模と予測 2023-2028
- 市場機会：地域情勢別
第9章 促進要因・課題・機会・抑制要因
- 市場促進要因
- 市場の課題
- 促進要因と課題の影響
- 市場の機会・抑制要因
第10章 競合情勢
- 概要
- 競合情勢
- 混乱の状況
- 業界のリスク
第11章 競合分析
- 企業プロファイル
- 企業の市場ポジショニング
- AbbVie Inc.
- Alimera Sciences Inc.
- Amgen Inc.
- Biogen Inc.
- Cadila Pharmaceuticals Ltd.
- EyePoint Pharmaceuticals Inc
- Johnson and Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
第12章 付録
図表
Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Product
- Exhibits6: Executive Summary - Chart on Incremental Growth
- Exhibits7: Executive Summary - Data Table on Incremental Growth
- Exhibits8: Executive Summary - Chart on Company Market Positioning
- Exhibits9: Parent Market
- Exhibits10: Data Table on - Parent Market
- Exhibits11: Market characteristics analysis
- Exhibits12: Value Chain Analysis
- Exhibits13: Offerings of companies included in the market definition
- Exhibits14: Market segments
- Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits19: Historic Market Size - Data Table on Global Uveitis Drugs Market 2018 - 2022 ($ million)
- Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
- Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits30: Chart on Product - Market share 2023-2028 (%)
- Exhibits31: Data Table on Product - Market share 2023-2028 (%)
- Exhibits32: Chart on Comparison by Product
- Exhibits33: Data Table on Comparison by Product
- Exhibits34: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
- Exhibits35: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
- Exhibits36: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
- Exhibits37: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
- Exhibits38: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
- Exhibits39: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
- Exhibits40: Chart on Biologics - Year-over-year growth 2023-2028 (%)
- Exhibits41: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
- Exhibits42: Market opportunity by Product ($ million)
- Exhibits43: Data Table on Market opportunity by Product ($ million)
- Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits47: Chart on Geographic comparison
- Exhibits48: Data Table on Geographic comparison
- Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits73: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits75: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits76: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits81: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibits82: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibits83: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits84: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits85: Market opportunity By Geographical Landscape ($ million)
- Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits87: Impact of drivers and challenges in 2023 and 2028
- Exhibits88: Overview on criticality of inputs and factors of differentiation
- Exhibits89: Overview on factors of disruption
- Exhibits90: Impact of key risks on business
- Exhibits91: Companies covered
- Exhibits92: Matrix on companies position and classification
- Exhibits93: AbbVie Inc. - Overview
- Exhibits94: AbbVie Inc. - Product / Service
- Exhibits95: AbbVie Inc. - Key news
- Exhibits96: AbbVie Inc. - Key offerings
- Exhibits97: Alimera Sciences Inc. - Overview
- Exhibits98: Alimera Sciences Inc. - Product / Service
- Exhibits99: Alimera Sciences Inc. - Key offerings
- Exhibits100: Amgen Inc. - Overview
- Exhibits101: Amgen Inc. - Product / Service
- Exhibits102: Amgen Inc. - Key news
- Exhibits103: Amgen Inc. - Key offerings
- Exhibits104: Biogen Inc. - Overview
- Exhibits105: Biogen Inc. - Product / Service
- Exhibits106: Biogen Inc. - Key news
- Exhibits107: Biogen Inc. - Key offerings
- Exhibits108: Cadila Pharmaceuticals Ltd. - Overview
- Exhibits109: Cadila Pharmaceuticals Ltd. - Product / Service
- Exhibits110: Cadila Pharmaceuticals Ltd. - Key offerings
- Exhibits111: EyePoint Pharmaceuticals Inc - Overview
- Exhibits112: EyePoint Pharmaceuticals Inc - Product / Service
- Exhibits113: EyePoint Pharmaceuticals Inc - Key offerings
- Exhibits114: Johnson and Johnson Services Inc. - Overview
- Exhibits115: Johnson and Johnson Services Inc. - Business segments
- Exhibits116: Johnson and Johnson Services Inc. - Key news
- Exhibits117: Johnson and Johnson Services Inc. - Key offerings
- Exhibits118: Johnson and Johnson Services Inc. - Segment focus
- Exhibits119: Novartis AG - Overview
- Exhibits120: Novartis AG - Business segments
- Exhibits121: Novartis AG - Key news
- Exhibits122: Novartis AG - Key offerings
- Exhibits123: Novartis AG - Segment focus
- Exhibits124: Pfizer Inc. - Overview
- Exhibits125: Pfizer Inc. - Product / Service
- Exhibits126: Pfizer Inc. - Key news
- Exhibits127: Pfizer Inc. - Key offerings
- Exhibits128: Regeneron Pharmaceuticals Inc. - Overview
- Exhibits129: Regeneron Pharmaceuticals Inc. - Product / Service
- Exhibits130: Regeneron Pharmaceuticals Inc. - Key offerings
- Exhibits131: Inclusions checklist
- Exhibits132: Exclusions checklist
- Exhibits133: Currency conversion rates for US$
- Exhibits134: Research methodology
- Exhibits135: Information sources
- Exhibits136: Data validation
- Exhibits137: Validation techniques employed for market sizing
- Exhibits138: Data synthesis
- Exhibits139: 360 degree market analysis
- Exhibits140: List of abbreviations
目次
Product Code: IRTNTR70329
Uveitis Drugs Market 2024-2028
The uveitis drugs market is forecasted to grow by USD 198.5 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the uveitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of eye disorders and associated risk factors of uveitis, recent advances in diagnostics of eye disorders, and strong pipeline.
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 4.23% |
| CAGR | 4.5% |
| Incremental Value | $198.5 mn |
Technavio's uveitis drugs market is segmented as below:
By Product
- Small molecules
- Biologics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the development of gene therapy as one of the prime reasons driving the uveitis drugs market growth during the next few years. Also, special designations and increasing popularity of combination therapies will lead to sizable demand in the market.
The report on the uveitis drugs market covers the following areas:
- Uveitis drugs market sizing
- Uveitis drugs market forecast
- Uveitis drugs market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading uveitis drugs market vendors that include AbbVie Inc., Alimera Sciences Inc., Amgen Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Biogen Inc., Cadila Pharmaceuticals Ltd., EyePoint Pharmaceuticals Inc, Hikma Pharmaceuticals PLC, Horizon Therapeutics PLC, Johnson and Johnson Services Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sebela Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the uveitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Uveitis Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Uveitis Drugs Market 2018 - 2022 ($ million)
- 4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
- 6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 6.3 Small molecules - Market size and forecast 2023-2028
- Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
- Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
- Chart on Small molecules - Year-over-year growth 2023-2028 (%)
- Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
- 6.4 Biologics - Market size and forecast 2023-2028
- Chart on Biologics - Market size and forecast 2023-2028 ($ million)
- Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
- Chart on Biologics - Year-over-year growth 2023-2028 (%)
- Data Table on Biologics - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 8.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- Companies covered
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 11.4 Alimera Sciences Inc.
- Alimera Sciences Inc. - Overview
- Alimera Sciences Inc. - Product / Service
- Alimera Sciences Inc. - Key offerings
- 11.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- 11.6 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- 11.7 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- 11.8 EyePoint Pharmaceuticals Inc
- EyePoint Pharmaceuticals Inc - Overview
- EyePoint Pharmaceuticals Inc - Product / Service
- EyePoint Pharmaceuticals Inc - Key offerings
- 11.9 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- 11.10 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 11.11 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 11.12 Regeneron Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key offerings
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- Research methodology
- 12.5 Data procurement
- Information sources
- 12.6 Data validation
- Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
- List of abbreviations
お電話でのお問い合わせ
044-952-0102
( 土日・祝日を除く )
